As GLP-1 drugs like Eli Lilly’s Mounjaro and Novo Nordisk’s Ozempic and Wegovy have spent the last couple of years skyrocketing in popularity—with no signs of slowing down—it was perhaps only a matter ...

Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending ...

Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, ...

Chronic care provider Omada Health is expanding its GLP-1 program to better care for patients interested in maintaining weight loss progress while discontinuing usage of the drugs. For patients ...

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a leading virtual-first healthcare provider, announced an expansion of its GLP-1 companion solution, adding customized partner support for medication ...

New Delhi: With India recording a sharp rise in early-onset obesity, insulin resistance and fatty liver disease, Metropolis Healthcare has rolled out three scientifically curated metabolic health ...

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare ...